Trending Stock News

Regeneron Pharmaceuticals (REGN) Share Price Rose While North Point Portfolio Managers Has Lifted Stake; Harvey Capital Management Increases Position in Range Resources (RRC)

North Point Portfolio Managers Corp increased its stake in Regeneron Pharmaceuticals (REGN) by 2.59% based on its latest 2017Q2 regulatory filing with the SEC. North Point Portfolio Managers Corp bought 756 shares as the company’s stock rose 21.24% with the market. The institutional investor held 30,000 shares of the health care company at the end of 2017Q2, valued at $14.73 million, up from 29,244 at the end of the previous reported quarter. North Point Portfolio Managers Corp who had been investing in Regeneron Pharmaceuticals for a number of months, seems to be bullish on the $40.99 billion market cap company. The stock decreased 0.84% or $3.23 during the last trading session, reaching $383.44. About 139,084 shares traded. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has risen 17.40% since December 17, 2016 and is uptrending. It has outperformed by 0.70% the S&P500.

Harvey Capital Management Inc increased its stake in Range Resources Corp (RRC) by 109.94% based on its latest 2017Q2 regulatory filing with the SEC. Harvey Capital Management Inc bought 56,395 shares as the company’s stock declined 18.29% while stock markets rallied. The institutional investor held 107,690 shares of the oil & gas production company at the end of 2017Q2, valued at $2.50M, up from 51,295 at the end of the previous reported quarter. Harvey Capital Management Inc who had been investing in Range Resources Corp for a number of months, seems to be bullish on the $3.82B market cap company. The stock decreased 2.25% or $0.36 during the last trading session, reaching $15.63. About 15.36M shares traded or 140.16% up from the average. Range Resources Corporation (NYSE:RRC) has declined 36.05% since December 17, 2016 and is downtrending. It has underperformed by 52.75% the S&P500.

Investors sentiment decreased to 1.35 in 2017 Q2. Its down 0.01, from 1.36 in 2017Q1. It dived, as 59 investors sold RRC shares while 108 reduced holdings. 45 funds opened positions while 180 raised stakes. 230.61 million shares or 4.36% more from 220.97 million shares in 2017Q1 were reported. New York-based Neuberger Berman Group Ltd Liability Com has invested 0% in Range Resources Corporation (NYSE:RRC). Huntington Bank & Trust accumulated 19 shares or 0% of the stock. Westwood Holding Group Inc Incorporated Inc invested 0% in Range Resources Corporation (NYSE:RRC). Moreover, Schaller Group has 2.37% invested in Range Resources Corporation (NYSE:RRC). Eaton Vance reported 0.02% in Range Resources Corporation (NYSE:RRC). Advantus Cap Management Inc accumulated 18,708 shares. Bnp Paribas Asset Management Holding Sa has invested 0.22% in Range Resources Corporation (NYSE:RRC). New Jersey Better Educational Savings invested in 0.4% or 20,000 shares. Credit Suisse Ag has invested 0.01% in Range Resources Corporation (NYSE:RRC). Dupont Corporation reported 3,507 shares. Picton Mahoney Asset Management holds 223,500 shares. Kingfisher Limited Liability Company reported 42,769 shares. Wafra Investment Advisory Grp Inc Inc Ny has 0.23% invested in Range Resources Corporation (NYSE:RRC). Credit Agricole S A holds 85,491 shares. 9,035 were reported by Bancorp Hapoalim Bm.

Among 40 analysts covering Range Resources Corp. (NYSE:RRC), 26 have Buy rating, 1 Sell and 13 Hold. Therefore 65% are positive. Range Resources Corp. had 127 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Drexel Hamilton given on Thursday, February 18. Morgan Stanley maintained the stock with “Equal-Weight” rating in Thursday, October 26 report. The rating was maintained by BMO Capital Markets with “Buy” on Friday, September 1. On Tuesday, September 5 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. GMP Securities reinitiated Range Resources Corporation (NYSE:RRC) on Wednesday, September 28 with “Buy” rating. The company was maintained on Monday, June 26 by BMO Capital Markets. The rating was maintained by Oppenheimer with “Hold” on Wednesday, August 19. The firm has “Neutral” rating given on Monday, March 21 by Macquarie Research. The stock of Range Resources Corporation (NYSE:RRC) has “Neutral” rating given on Monday, September 14 by Citigroup. The firm has “Underweight” rating by Barclays Capital given on Wednesday, September 28.

Among 31 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 13 have Buy rating, 1 Sell and 17 Hold. Therefore 42% are positive. Regeneron Pharmaceuticals Inc. had 102 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating given on Friday, October 6 by Morgan Stanley. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has “Buy” rating given on Friday, August 21 by Vetr. BMO Capital Markets maintained Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) rating on Tuesday, July 18. BMO Capital Markets has “Hold” rating and $48400 target. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) earned “Buy” rating by Canaccord Genuity on Wednesday, August 5. UBS maintained it with “Sell” rating and $565 target in Wednesday, August 5 report. On Wednesday, June 29 the stock rating was initiated by Bernstein with “Outperform”. The stock of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has “Hold” rating given on Monday, July 31 by Cowen & Co. On Monday, April 4 the stock rating was maintained by Roth Capital with “Buy”. The firm has “Buy” rating given on Thursday, August 6 by Argus Research. On Friday, December 4 the stock rating was initiated by Wells Fargo with “Outperform”.

Investors sentiment increased to 1.38 in 2017 Q2. Its up 0.12, from 1.26 in 2017Q1. It increased, as 42 investors sold REGN shares while 157 reduced holdings. 84 funds opened positions while 190 raised stakes. 71.53 million shares or 1.38% more from 70.55 million shares in 2017Q1 were reported. Keybank National Association Oh invested 0.01% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Polen Cap Limited Liability Co invested in 6.81% or 1.59 million shares. Qcm Cayman accumulated 595 shares or 0.67% of the stock. Manning Napier Advisors Limited Liability Co accumulated 298,778 shares. Wells Fargo And Mn invested 0.06% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Ameriprise Fincl Inc has 217,208 shares. 180 were accumulated by Mitsubishi Ufj Secs. Gsa Capital Ptnrs Llp holds 0.02% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) or 549 shares. Goldman Sachs Group owns 372,267 shares. Bokf Na holds 0.15% of its portfolio in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for 9,474 shares. Architects invested 0.01% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Mitsubishi Ufj And Banking Corporation stated it has 158,407 shares or 0.15% of all its holdings. Polar Capital Llp owns 98,763 shares. Trust Company Of Vermont reported 27 shares. The Texas-based Salient Cap Limited Liability Company has invested 0% in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN).

Since August 7, 2017, it had 2 insider purchases, and 8 sales for $78.43 million activity. Shares for $210,693 were sold by Landry Robert E. $900,000 worth of stock was sold by BAKER CHARLES A on Friday, September 29. Sanofi bought 72,378 shares worth $34.84 million. 1,500 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares with value of $712,500 were sold by BROWN MICHAEL S.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *